Skip to main content
Premium Trial:

Request an Annual Quote

Cellecta Dual-sgRNA Libraries

Cellecta has commercially launched its dual-sgRNA libraries designed for CRISPR activation (CRISPRa) and CRISPR interference/repression (CRISPRi) genetic screens. With the modified systems, the firm said it has re-engineered the standard knockout capacity to modulate gene activitiy. The variations extend the types of genetic screenings possible. 

According to Cellecta, its dual-sgRNA CRISPRa and CRISPRi libraries improve single-sgRNA library activity because each construct expresses two different sgRNA binding distinct sites on the promoter of each gene target. The firm believes this advantage increases the likelihood that each targeted gene will be activated or repressed above a given threshold when compared to libraries that only have a single sgRNA targeting a gene promoter. 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.